Oculis Holding AG (OCS) Change in Cash (2022 - 2026)
Oculis Holding AG's (OCS) quarterly Change in Cash came in at -$22.0 million in Q1 2026, down 159.36% year-on-year from $37.1 million in Q1 2025, and down 150.45% quarter-over-quarter from $43.7 million in Q4 2025.
Oculis Holding AG (OCS) Change in Cash (2022 - 2026) Analysis & Trends
Oculis Holding AG's Change in Cash history runs 5 years deep, the most recent figure standing at -$22.0 million for Q1 2026.
- On a quarterly basis, Change in Cash fell 159.36% year-over-year to -$22.0 million in Q1 2026; TTM through Mar 2026 was $10.5 million, a 74.29% decrease from a year earlier, with the FY2025 full-year figure at $72.0 million, up 674.33% from the prior year.
- Change in Cash retreated to -$22.0 million in Q1 2026 per OCS's latest filing, from $43.7 million in the prior quarter.
- Across five years, Change in Cash topped out at $86.1 million in Q1 2023 and bottomed at -$57.7 million in Q2 2023.
- The 5-year median for Change in Cash is -$8.1 million (2024), against an average of $2.8 million.
- Across the five-year window, Change in Cash tumbled 205.76% in 2023 and surged 536.38% in 2025, its largest moves.
- Year by year, Change in Cash stood at -$8.6 million in 2022, then jumped by 219.37% to $10.3 million in 2023, then plunged by 196.97% to -$10.0 million in 2024, then jumped by 536.38% to $43.7 million in 2025, then slumped by 150.45% to -$22.0 million in 2026.
- Per Business Quant, the three latest OCS Change in Cash figures stand at -$22.0 million (Q1 2026), $43.7 million (Q4 2025), and -$22.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 243.78 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 57.19 Mn |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 53.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.03 Mn |
| Dec 31, 2025 | 43.66 Mn |
| Sep 30, 2025 | -22.16 Mn |
| Jun 30, 2025 | 11.04 Mn |
| Mar 31, 2025 | 37.11 Mn |
| Dec 31, 2024 | -10.01 Mn |
| Sep 30, 2024 | -8.06 Mn |
| Jun 30, 2024 | 21.88 Mn |
| Mar 31, 2024 | -17.26 Mn |
| Dec 31, 2023 | 10.32 Mn |
| Sep 30, 2023 | -17.36 Mn |
| Jun 30, 2023 | -57.67 Mn |
| Mar 31, 2023 | 86.12 Mn |
| Dec 31, 2022 | -8.64 Mn |
| Sep 30, 2022 | -5.68 Mn |